Germany's Bayer AG , which completed the takeover of U.S.-based Monsanto la...
), which completed the takeover of U.S.-based Monsanto last year, has been dealt a legal blow in Brazil as more farmers joined a lawsuit challenging the protection of a key soy seed patent.
That means Bayer, which had been ordered to deposit royalties received from the Mato Grosso growers in an escrow account, will have to do the same with royalties from the new plaintiffs, said Sidney Pereira de Souza Jr, an attorney representing the soy growers who cited court decisions granted in July 26 and on Feb. 25.
Recently, Brazilian cotton growers challenged Bayer’s patent protection for the Bollgard II RR Flex seed.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Boy, 8, dies in Germany after being pushed onto train tracksAn 8-year-old boy died when a man pushed him and his mother onto the tracks at Frankfurt's main train station. A suspect was arrested and police say he had no apparent connection to the victims.
Consulte Mais informação »
European Court Rules In Favor Of Kraftwerk In 20 Year-Long Copyright DisputeA nearly 20-year legal battle over the unauthorized sampling of a Kraftwerk song appears to finally be at an end after the European Court of Justice ruled in favor of the pioneering German group.
Consulte Mais informação »
American Milk Myth: New Undercover Investigation Challenges Organic MilkA new animal welfare investigation says organic dairy cows are no better off than conventional. But a representative for the Organic Trade Association says what's really needed is stronger enforcement of the existing organic regulations.
Consulte Mais informação »
American Milk Myth: New Undercover Investigation Challenges Organic MilkA new animal welfare investigation says organic dairy cows are no better off than conventional. But a representative for the Organic Trade Association says what's really needed is stronger enforcement of the existing organic regulations.
Consulte Mais informação »
Mylan skyrockets after securing a merger with Pfizer's off-patent drug unitThe new company will sell popular drugs such as Viagra, Lipitor, and Mylan's EpiPen, and is expected to generate around $20 billion in total sales.
Consulte Mais informação »
Mylan to combine with Pfizer's off-patent medicines unitPfizer Inc will separate its off-patent drugs business and merge it with Mylan ,...
Consulte Mais informação »